Panic Disorder Associated With Clozapine
Ms. A, a 34-year-old woman, was first seen for psychiatric treatment at age 30 after experiencing 2 months of psychotic symptoms. She described hearing threatening voices saying that they wanted to cut her fingers. She suspected that her mother’s doctors had formed an organization to harm her and that these doctors could hear her thoughts by means of a “neurotransmitter” installed inside her head. Treatment with two typical antipsychotics (haloperidol, 30 mg/day, and trifluoperazine, 40 mg/day) and one atypical antipsychotic (risperidone, 8 mg/day) resulted in no significant improvement in her symptoms. After 8 months of unsuccessful treatment, including two hospital admissions, the diagnosis of treatment-resistant paranoid schizophrenia (per DSM-IV) was confirmed, and Ms. A was treated with clozapine. Clozapine monotherapy (400 mg/day) led to a marked improvement in positive symptoms, but Ms. A remained a bit withdrawn. In the 20th week of clozapine treatment, Ms. A developed clozapine-induced sinus tachycardia and the fear of dying of a heart attack. She was effectively medicated with a β blocker (atenolol, 100 mg/day). Despite a normal ECG and the exclusion of other organic causes, Ms. A experienced recurrent attacks of sudden chest compression, dizziness, fear of dying, and intense anxiety. She often went to emergency clinics, where her symptoms were treated with benzodiazepines. Her panic symptoms occurred daily, and she developed agoraphobic symptoms that confined her to the house and compromised her rehabilitation.When assessed by a blind rater with the Structured Clinical Interview for DSM-IV, Ms. A fulfilled the DSM-IV criteria for paranoid schizophrenia and panic disorder with agoraphobia. The temporal relationship between clozapine treatment and the development of panic attacks suggested that clozapine could have been inducing the panic symptoms. Reduction of clozapine therapy to 250 mg/day led to a modest improvement in Ms. A’s anxiety symptoms but some worsening of her psychotic symptoms. Olanzapine (10 mg/day) was then substituted for clozapine without recurrence of the psychotic symptoms. Her panic symptoms progressively improved, and 2 months after switching antipsychotics, Ms. A patient was stable, with some negative symptoms but no panic or agoraphobic symptoms.
References
Information & Authors
Information
Published In
History
Authors
Metrics & Citations
Metrics
Citations
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
View Options
View options
PDF/EPUB
View PDF/EPUBGet Access
Login options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).